Twenty-seven eyes (11 right and 16 left) in 26 patients (12 males and 14 females) were included in our study. The mean period of follow-up was 30 months (range 3-93 months), and the average age of the patients was 72 years (range 47-84).
In all but five eyes prior to PRP the fundus lesions had been recorded by fundus photography and fluorescein angiography. In these five cases there was vitreous haemorrhage obscuring fundal details. Iris neovascularisation had been detected by observation of the iris and gonioscopy. The fluorescein angiograms were taken of the optic disc, posterior pole, and equatorial surveys. It was noted whether or not there was posterior segment neovascularisation, and the number of quadrants ofretinal ischaemia were assessed from the amount of capillary nonperfusion.
Where no clinical review had been performed within the last three months the patients were recalled and repeat examinations performed, including repeat fundus photography and fluorescein angiography.
Results
Twenty one eyes had fluorescein angiography prior to PRP; 17 eyes had four quadrants of capillary closure and four eyes three or fewer. In the former group eight had rubeosis and four posterior segment new vessels, and in the latter group all eyes had rubeosis iridis with a mean interval between presumed onset and PRP of four months (range three-six months). Six did not have a fluorescein angiogram before photocoagulation, as it was thought to be unnecessary for treatment: five already had rubeosis iridis and one a vitreous haemorrhage.
The pattern of neovascularisation prior to PRP and on final review in each individual patient is shown in Table 1 together with the period from probable onset of CRVO to PRP. The presenting and final patterns of neovascularisation and the regression and formation of new vessels after PRP are shown in Table 2 . New vessels on the iris were present in 17 eyes at the time of PRP and new vessels on the disc or elsewhere in the retina in seven eyes. New vessels on the iris were successfully treated in 11 eyes and did not occur at any. stage in nine eyes (Table 1 ). There were five eyes (19-23, Table 1 ) in which new vessels on the iris were either absent or had resolved following photocoagulation but in which posterior segment new vessels subsequently developed.
New vessels on the iris were present when the time between the probable onset (when the patient first noticed visual loss) of the CRVO and PRP was shortest (four months), new vessels on (Table 3) . Where rubeosis iridis occurred alone the average time from probable onset of CRVO to PRP was 4-3 months, the '100-day glaucoma', and this occurred in 16 eyes (59%). Where only posterior segment neovascularisation was present, the average time from CRVO onset to PRP was much longer (12 months). This was seen in only five eyes (19%). Those eyes with no neovascular response at the time of laser therapy showed an intermediate time months) between probable onset of CRVO and PRP. This may suggest either that the stimulus to anterior segment neovascularisation, when present, is more intense than the stimulus to posterior segment neovascularisation or that the neovascular response of the anterior segment, once it is supplied with a hypoxic stimulus, is more rapid than that from the posterior segment. Finally it has been suggested that new vessels on the disc or elsewhere may indicate restoration of the retinal circulation9 with a concomitant reduction in the production of an 'angiogenic factor.' This may then be insufficient to stimulate new vessels on the iris. Overall PRP was effective in inducing regression of or prophylaxis against new vessels on the iris (Table 2) but not so effective for posterior segment new vessels.
The most interesting feature ofour study is the five eyes in which rubeosis either had been absent or had resolved following photocoagulation but in which posterior segment new vessels subsequently developed, whether on the disc, or elsewhere in the retina, or as shown by the presence of vitreous haemorrhage. As the posterior segment neovascularisation occurred some time after PRP, it is unlikely that a post-PRP inflammatory response was responsible for the appearance of new vessels on the disc or retina.
There is growing evidence that the neovascular response occurs due to an alteration induced by retinal hypoxia in the balance among proliferative and inhibitory growth factors produced by the retina and associated structures.' 10 " The original rationale for PRP was to reduce the amount of hypoxic retina and therefore reduce neovascularisation. More recent evidence suggests that photocoagulation alters the balance of the growth factors in favour of new vessel regression.
We propose a concept that, if an ischaemic CRVO occurs, the neovascular response of the affected eye varies according to the amount of hypoxic retina (Table 4) , which can in turn be altered by PRP. If hypoxia is severe, the eye responds by developing marked rubeosis iridis within three months -100-day glaucoma. If the hypoxia is moderate then new vessels may develop on either the iris or at the posterior pole, but these occur Neovascularresponse in ischaemic central retinal vein occlusion afterpanretinal photocoagulation said9 that ifnew vessels on the disc or retina occur the eye is saved, but if they occur on the iris then the eye is lost. Therefore converting an eye with new vessels on the iris to one with them on the disc or elsewhere on the retina may be an acceptable goal for PRP.
